Greenwood Capital Associates’s Synovus SNV Stock Holding History

Greenwood Capital Associates’s Portfolio SNV Stock Details SNV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,809	Closed	-$641K	–	308
2025 Q4	$641K	Sell	12,809 -23,842	-65%	-$1.15M	0.07%	162
2025 Q3	$1.8M	Sell	36,651 -898	-2%	-$46K	0.21%	100
2025 Q2	$1.94M	Sell	37,549 -2,697	-7%	-$124K	0.24%	95
2025 Q1	$1.88M	Buy	40,246 +10,519	+35%	+$543K	0.25%	94
2024 Q4	$1.52M	Sell	29,727 -1,145	-4%	-$59.3K	0.2%	96
2024 Q3	$1.37M	Buy	+30,872	New	+$1.35M	0.18%	108

Other funds holding SNV

WBWA

William B. Walkup & Associates Columbia, South Carolina $208M AUM 37.34% 1-Year Est. Return

Greenwood Capital Associates's SNV Position: Q1 2026 in Review

Greenwood Capital Associates sold out of Synovus (SNV) in Q1 2026, closing a stake of 12,809 shares — an estimated $641K sold.

Greenwood Capital Associates first reported a position in SNV in Q3 2024 and held it in 6 quarters. The position peaked at $1.94M in Q2 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

Greenwood Capital Associates reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
Greenwood Capital Associates sold 12,809 Synovus shares in Q1 2026, an estimated $641K.
Greenwood Capital Associates first reported a position in Synovus in Q3 2024 and held it in 6 quarters.
Greenwood Capital Associates's Synovus position peaked at $1.94M in Q2 2025.
1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Greenwood Capital Associates's 13F filing for Q1 2026, filed 29 Apr 2026.